April 23, 2021
Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.
April 14, 2021
The CDC and the FDA are reviewing data involving six U.S. cases of a rare type of blood clot in individuals after receiving the Johnson & Johnson (J&J) COVID-19 vaccine that were reported to the Vaccine Adverse Events Reporting System (VAERS).
April 8, 2021
A lawsuit has been filed against Roper St. Francis alleging a breach of private patient data, including financial and medical information, was compromised.
April 2, 2021
The Centers for Disease Control and Prevention (CDC) updated its travel guidance for fully vaccinated people to reflect the latest evidence and science.
March 19, 2021
A bill headed through the S.C. Statehouse would require doctors to offer lifesaving overdose reversal drugs to some patients who might potentially need them, even as the largest physicians’ lobbying group in the state expresses concern the law would be an overreach.
March 16, 2021
Vaccination of about 88% of Americans who received the first dose of Pfizer/BioNTech or Moderna’s COVID-19 vaccines was complete, a study of over 12 million people by the U.S. Centers for Disease Control and Prevention (CDC) showed.
March 1, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
February 15, 2021
In accordance with IRS regulations for federal income tax purposes, a percentage of SCMA annual membership dues may be deducted as a business expense. The SCMA estimates 87.38% of 2020 membership dues are deductible.
February 4, 2021
Emergency Room physicians brought up the issue of EPT, or the “clinical practice of treating the sex partners of patients diagnosed with chlamydia or gonorrhea by providing prescriptions or medications to the patient to take to his/her partner without the health care provider first examining the partner